Metabolomics

Published by: RI Technologies

Published: Jan. 1, 2008 - 182 Pages

Table of Contents

I. SCOPE AND METHODOLOGY

II. REPORT SYNOPSIS

1. Introduction

Segmentation of Metabolomics Technologies

2. Global Market Analysis

Exhibit 1: Metabolomics (2005-2012) - Global Market Analysis (Current & Future) in US$ Million (Graphical Representation included)

Analysis by Metabolomics Technologies

Combined Systems - The Fastest Growing Technology

Market Analysis

Exhibit 2: Combined Systems of Metabolomics (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan, Asia-Pacific, Canada and Rest of World in US$ Million (Graphical Representation included)

Exhibit 3: Combined Systems of Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan, Asia-Pacific, Canada and Rest of World (Graphical Representation included)

Hardware Systems - The Fading-out Technology

Exhibit 4: Hardware Systems of Metabolomics (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan, Asia-Pacific, Canada and Rest of World in US$ Million (Graphical Representation included)

Exhibit 5: Hardware Systems of Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan, Asia-Pacific, Canada and Rest of World

Software Systems - Ever Growing in Emerging Markets

Market Analysis

Exhibit 6: Software Systems of Metabolomics (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan, Asia-Pacific, Canada and Rest of World in US$ Million (Graphical Representation included)

Exhibit 7: Software Systems of Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan, Asia-Pacific, Canada and Rest of World

Exhibit 8: List of Major Global Companies

3. Regional Market Analysis

North America

Exhibit 9: Metabolomics (2005-2012) - North American Market Analysis (Current & Future) in US$ Million (Graphical Representation included)

Major Companies in North America

Acadia Pharmaceuticals, Inc. (USA)

Accelrys, Inc. (USA)

Agilent Technologies, Inc. (USA)

Amphora Discovery Corporation (USA)

Applied Biosystems Group (USA)

BG Medicine, Inc. (USA)

Bio-Rad Laboratories, Inc. (USA)

Bruker Biosciences Corporation (USA)

Bruker Daltonics, Inc. (USA)

Caliper Life Sciences, Inc. (USA)

Chenomx, Inc. (Canada)

Cogenics (USA)

Genego, Inc. (USA)

Infometrix, Inc. (USA)

MDS Sciex (Canada)

Metabolon, Inc. (USA)

Pharmaceutical Product Development, Inc. (USA)

Phenomenome Discoveries, Inc. (Canada)

SiDMAP (USA)

Thermo Fisher Scientific, Inc. (USA)

Waters Corporation (USA)

Analysis by Metabolomics Technologies

Combined Systems

Exhibit 10: Combined Systems of Metabolomics (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for United States and Canada in US$ Million (Graphical Representation included)

Exhibit 11: Combined Systems of Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for United States and Canada (Graphical Representation included)

Hardware Systems

Exhibit 12: Hardware Systems of Metabolomics (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for United States and Canada in US$ Million (Graphical Representation included)

Exhibit 13: Hardware Systems of Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for United States and Canada (Graphical Representation included)

Software Systems

Exhibit 14: Software Systems of Metabolomics (2005-2012) - North American Market Analysis (Current & Future) by Geographic Region for United States and Canada in US$ Million (Graphical Representation included)

Exhibit 15: Software Systems of Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of North American Market Value by Geographic Region for United States and Canada (Graphical Representation included)

Europe

Exhibit 16: Metabolomics (2005-2012) - European Market Analysis (Current & Future) in US$ Million (Graphical Representation included)

Major Companies in Europe

Avogadro (France)

Biocrates Life Sciences AG (Austria)

Genedata AG (Switzerland)

Metabometrix Ltd. (UK)

Metanomics GmbH (Germany)

Analysis by Metabolomics Technologies

Combined Systems

Exhibit 17: Combined Systems of Metabolomics (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden and Rest of Europe in US$ Million (Graphical Representation included)

Exhibit 18: Combined Systems of Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden and Rest of Europe (Graphical Representation included)

Hardware Systems

Exhibit 19: Hardware Systems of Metabolomics (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden and Rest of Europe in US$ Million (Graphical Representation included)

Exhibit 20: Hardware Systems of Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden and Rest of Europe (Graphical Representation included)

Software Systems

Exhibit 21: Software Systems of Metabolomics (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden and Rest of Europe in US$ Million (Graphical Representation included)

Exhibit 22: Software Systems of Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden and Rest of Europe (Graphical Representation included)

Asia-Pacific

Exhibit 23: Metabolomics (2005-2012) - Asia-Pacific Market Analysis (Current & Future) in US$ Million (Graphical Representation included)

Analysis by Metabolomics Technologies

Combined Systems

Exhibit 24: Combined Systems of Metabolomics (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for China, India, Australia and Rest of Asia-Pacific in US$ Million (Graphical Representation included)

Exhibit 25: Combined Systems of Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for China, India, Australia and Rest of Asia-Pacific (Graphical Representation included)

Hardware Systems

Exhibit 26: Hardware Systems of Metabolomics (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for China, India, Australia and Rest of Asia-Pacific in US$ Million (Graphical Representation included)

Exhibit 27: Hardware Systems of Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for China, India, Australia and Rest of Asia-Pacific (Graphical Representation included)

Software Systems

Exhibit 28: Software Systems of Metabolomics (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for China, India, Australia and Rest of Asia-Pacific in US$ Million (Graphical Representation included)

Exhibit 29: Software Systems of Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for China, India, Australia and Rest of Asia-Pacific (Graphical Representation included)

Rest of World

Exhibit 30: Metabolomics (2005-2012) - Rest of World Market Analysis (Current & Future) in US$ Million (Graphical Representation included)

III. PRODUCT/TECHNOLOGY RESEARCH

1. Introduction

Backdrop

Metabolomics - The Definition

History of Metabolomics

Metabolomic Profiling

Separation Methods

Detection Methods

Metabolomics Growth Trends - Global Markets

Exhibit 31: Global Market for Metabolomics: Geographic Regions (Asia-Pacific, Canada, Europe, Japan and United States) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation included)

Metabolomic Profiling - The Applications

Toxicity Assessment/Toxicology

Functional Genomics

The Human Metabolome Project

Human Metabolome Database

Systems Biology Or Integrative Biology

Biomolecular Networks

HiRes

Computer Simulation of Metabolism

Computer Simulation and the Design of Drugs

Metabolic Activity Preservation in Lyophilized Human Erythrocytes

Metabolic flux Ratio Study on Escherichia coli Mutants Using GC-MS Method

Metabolic profiling

Metabolomic Profiling - The Technologies

The LC-MS Technique

Liquid Chromatographic Radioactivity Detection Techniques

Structural Genomics in Combination with Metabolic Profiling

Techniques for Redox Metabolic Profiling

Metabolomics and Metabonomics

Metabolism: Metabolites and Metabolome

Metabolites

Metabolome

Human Nutrition Metabolome

Metabolomics and Human Health

Metabolomic Techniques for Genetic Mapping

Human Metabolic Diagnosis

Metabolomics in Human Nutrition - Prospects and Experiments

The Human Nutrition Metabolome Generation

Pattern-Recognition Methods and Human Nutrition

Nutrition Evaluation with Pharmacology and Toxicology

How Metabolites Affect Food

Metabolomics - Related with other Omics?

Proteomics, Genomics and Metabolomics

Functional Genomics

The Shortcomings/Delays in Functional Genomics Strategies

Proteomics

Lipidomics

The Definition

The Concept of Lipidomics

Traditional Analysis of Lipids

Lipidomics Aids Treatment of CNS Related Diseases

Glycomics

Study of Glycobiology - Analytical High-Throughput Technologies

Transcriptomics

Arabidopsis Thaliana

Signal Transduction Process

Dietary Leucine Excess

Analysis of Metabolic Pathways

Types of Metabolic Pathways Databases

MMCD

BRENDA

EMP

Enzyme Nomenclature Database

IntEnz

Kinase Pathway Database

PhosphaBase

PRECISE

TECRDB

BOCD

EcoCyc

KEGG Metabolic Pathways

Boehringer Mannheim - Biochemical Pathways

Environmental Metabolomics

Components for the Study of Metabolomics

Challenges to Environmental Metabolomics

Advantages of Metabolomics

Other Side of the Coin

Metabolomics to Probe GM foods

2. Metabolomics Technologies

Sophisticated Analytical Tools Required in Metabolomics

Scope for Growth in NMR-based Analysis

The Bottom-up Approach

Blood as a Central Focus Theme

An Individualized Approach to Metabolomics

Growth Trends - Global Biomarker Discovery Technologies

Exhibit 32: Global Market for Metabolomics: Metabolomics Technologies (Combined Systems, Hardware Systems and Software Systems ) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation included)

Categorization of Metabolomics Technologies

Mass Spectrometry

Applications of Mass Spectrometers

Protein Detection and Analysis

Protein Quantitation

Growth Trend for Combined Systems

Exhibit 33: Global Market for Combined Systems for Metabolomics: Geographic Regions (Canada, Europe, Asia-Pacific, Japan and United States) Ranked by Projected CAGR for 2005 through 2012 (Graphical Representation included)

Protein Structure Probing

Space Exploration

Respiratory Gas Monitoring

Isotope Ratio Evaluation

Exposure and Burial Dating

Growth Trend for Software Systems

Exhibit 34: Global Market for Software Systems for Metabolomics: Geographic Regions (Asia-Pacific, Europe, Canada, Japan and United States) Ranked by Projected

CAGR for 2005 through 2012 (Graphical Representation included)

Trace Gas Analysis

Pharmacokinetics

Metabolites Identification and Biomarkers Development

Nuclear Magnetic Resonance

Fourier Spectroscopy

Multi-Dimensional - A Type of FT-NMR

NMR Based Metabolomics

Applications of NMR

Liquid Chromatography/Gas Chromatography

High Performance Liquid Chromatography

Lab-on-a-Chip

Capillary Electrophoresis

Electrochemical Array

Application of Electrochemical Array Detection in Metabolomics

Fourier-Transform Infrared Spectroscopy

Qualitative Analysis with FT - IR7

Challenges for Metabolomics

3. Metabolomics - A Pharma and Healthcare Perspective

Metabolomics - Significance of Individual Health

Need for Awareness of Balanced Diet

Creation of Basic Structure

The Creation Stage

Development of Technologies

Database Collection on Personalized Metabolites Health

The Innovation Stage

Metabolism’s Role in Physical Condition

Pathways Ideal for Classifying Targets and Techniques

The Execution Stage

Execution of Personalized Evaluation Technologies

Clinical Chemistry and Metabolomics

Metabolomics in Biomarker Identification

Metabolite Biomarkers

Study of Biomarker Metabolites in Oryza Sativa (Rice)

Limitations of Metabolite Biomarkers

Personalized Medicine with Metabolomics

Pharmaco-Metabonomics

Application of Metabolomics in Transplantation

Exhibit 35: Reported Frequencies of Organ Transplantations (2006): Percentage Breakdown of Frequencies for Kidney, Liver, Heart, Pancreas and Lung Transplantations (Graphical Representation included)

The Role of Metabolomics in Transplantation of Various Organs

Kidney Transplantation

Liver Transplantation

Heart Transplantation

Metabolomics - In the Process of Drug Discovery

Metabolomics to Save Time and Cost in Initial Stages

Distinguishing Varieties of Animal Phenotypes

Biomarker Detection

Metabolic Profiling Approach for Biomarker Discovery

ESI-LC/MS Use in Identifying Biomarkers in Plant Extracts

Metabolic Profiles and Biomarkers Determine Toxic Drug Effects

IV. MARKET DYNAMICS

1. Market Overview

Global Market Analysis

Exhibit 36: Metabolomics (2005-2012) - Global Market Analysis (Current & Future) by Geographic Region for United States, Europe, Japan, Asia-Pacific, Canada and Rest of World in US$ Million (Graphical Representation included)

Exhibit 37: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Global Market Value by Geographic Region for United States, Europe, Japan, Asia-Pacific, Canada and Rest of World (Graphical Representation included)

2. Major Companies in Metabolomics Industry

Acadia Pharmaceuticals, Inc. (USA)

Accelrys, Inc. (USA)

Agilent Technologies, Inc. (USA)

Amphora Discovery Corporation (USA)

Applied Biosystems Group (USA)

Avogadro (France)

BG Medicine, Inc. (USA)

Biocrates Life Sciences AG (Austria)

Bio-Rad Laboratories, Inc. (USA)

Bruker Biosciences Corporation (USA)

Caliper Life Sciences, Inc. (USA)

Chenomx, Inc. (Canada)

Cogenics (USA)

Genedata AG (Switzerland)

Genego, Inc. (USA)

Human Metabolome Technologies, Inc. (Japan)

MDS Sciex (Canada)

Metabolon, Inc. (USA)

Metabometrix Ltd. (UK)

Metanomics GmbH (Germany)

Pharmaceutical Product Development, Inc. (USA)

Phenomenome Discoveries, Inc. (Canada)

Shimadzu Corporation (Japan)

SiDMAP (USA)

Thermo Fisher Scientific, Inc. (USA)

Waters Corporation (USA)

3. Major Activities in Metabolomics Industry

UCB Collaborates with BioSeek for Evaluation of Compounds with BioMAP Systems

Bruker BioSciences to Acquire Privately Held Bruker BioSpin’s Companies

Agreement Gives U.S Food and Drug Administration an Access to Genedata Expressionist Platform

GeneGo Grants License for Usage of MetaCore to Oregon Health and Science University (OHSU)’s Facility

Metabolon Collaborates with US Army Medical Research Institute of Infectious Diseases

Metabolon Acquires Cogenics Icoria’s Patented Metabolomics and Toxicity Technologies

Bionas Enters into a Service Contract with Solvay Pharmaceuticals

GeneGo Licenses MetaCore to Biogen Idec

Chenomx Partners with GeneGo to Provide Metabolomics Data Integration

** HMT Explains the Cause of Heterogeneity in Bacillus Subtilis Populations

Chenomx Inc. Awarded two Patents for NMR-based Mixture Analysis Computations

Nanosys and Bruker Daltonics Collaborate for Research, Development and Distribution of NALDI(TM)-TOF

MDS Acquires Entire Stake in MDC

Agilent Technologies Collaborates with Lipomics for Developing Research and Diagnostic Biomarker Assays

BG Medicine and Applied Biosystems Collaborate for Improving Biomarker Discovery and Development

AstraZeneca Employs ToxWiz to Determine the Effects of Liver Treatment Drugs

Nycomed Acquires ALTANA Pharma AG

Bayer AG Takes Over Schering AG

GeneData Collaborates with Serono for Intensifying Analysis on Screening

GenoLogics’ Proteus™ to be Utilized by University of Leuven

GenoLogics’ Geneus Solution to be Utilized for Genomics Research

Clinical Data Signs Pact with QTC

Ariadne Grants Pathway Studio License to NCI

GeneData Enters into Collaboration with Altanta and Introduces Hit Profiler

Agilent Signs Agreement with Mass Consortium

Bruker BioSciences Acquires Stake in Bruker Optics

GeneData Signs Partnership Agreement with INCA

Shimadzu Signs Partnership Agreement with Phenomenome

PathwayStudio® 4.0 of Ariadne Links up with Affymetrix GeneChip-compatible Applications Program

Cerep Signs Licensing Agreement with AstraZeneca

Chenomx Joins Hands with Umetrics to Offer Metabolomics Solutions

Biocrates signs Alliance Agreement with Altana…

Bio-Rad Enters into Partnership with Infometrix

NCTR Establishes Metabolomics Research Center

Syngenta Acquires Licenses from InforSense

Clinical Data Initiates Metabolomics Research of Lung Cancer Samples

CST Extends Agreement with AstraZeneca

Allied Biosystems Signs Alliance Agreement with MDS and Biocrates

PrecisionMed Enters into Collaboration with Phenomenome

PPD Takes Over SurroMed

4. Major Product Innovations/Launches in Metabolomics Industry

Chenomx, Inc. Launches the Upgraded Version of Metabolomics Software Solution

Metabolon to Provide mVision™ Service for Biomarker Discovery

Chenomx Inc. Introduces Metabolic Profiling Services

Applied Biosystems Launches StepOne™ Real-Time PCR System

Applied Biosystems Introduces TaqMan®

Discovery of APG16L1 as a New Gene Related to Crohn’s Disease

InnoMed Introduces a New Website for Data Transmission

GenoLogics Discovers Sophisticated Data Management Solutions for Various Applications

Phoenix Launches SureSpray Technology

Bio-Rad Releases Version 7.5 of its KnowItAll Informatics System

GenoLogics Introduces Geneus™

Ariadne Introduces Additional Pathway Database for PathwayStudio® and PathwayExpert™ Software

Thermo Electron (now Thermo Fisher Scientific) Launches Galileo LIMS v 3.2

Agilent Launches Liquid Chromatography Column

Ariadne Introduces New Software for Pathway Analysis

GeneData Launches Expressionist® Pro 3.0

Applied Biosystems and MDS Unveil MIDAS™ TRAQ Systems

Allied Biosystems and MDS Introduce Tempo™, a Liquid Chromatography System

GenoLogics Develops OmixLIMS

GeneGo Incorporates Accord Technology in MetaDrug™

Applied Biosystems and MDS Sciex Unveil MarkerView™ Software

Phenomenome Develops Solution for Colorectal Cancer Screening

Bio-Rad Laboratories Introduces ADMET Databases

Thermo Electron (now Thermo Fisher Scientific) Introduces LeadStream ADME/Tox Solution™ 139

5. Regional Market Analysis

A. The United States

Market Analysis

Exhibit 38: Metabolomics (2005-2012) - United States Market Analysis (Current & Future) in US$ Million (Graphical Representation included)

Exhibit 39: List of Major Companies in the United States

Analysis by Metabolomics Technology

Exhibit 40: Metabolomics (2005-2012) - United States Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)

Exhibit 41: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of United States Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems

B. Europe

Market Analysis

Exhibit 42: Metabolomics (2005-2012) - European Market Analysis (Current & Future) in US$ Million (Graphical Representation included)

Exhibit 43: List of Major Companies in Europe

Analysis by Geographic Region

Exhibit 44: Metabolomics (2005-2012) - European Market Analysis (Current & Future) by Geographic Region for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden and Rest of Europe in US$ Million (Graphical Representation included)

Exhibit 45: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Geographic Region for Germany, United Kingdom, Italy, Belgium, France, Spain, Switzerland, Sweden and Rest of Europe (Graphical Representation included)

Analysis by Metabolomics Technology

Exhibit 46: Metabolomics (2005-2012) - European Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)

Exhibit 47: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of European Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million

European Metabolomics Market by Country

B1. Germany

German Market Analysis

Analysis by Metabolomics Technology

Exhibit 48: Metabolomics (2005-2012) - German Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)

Exhibit 49: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of German Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million

B2. The United Kingdom

UK Market Analysis

Analysis by Metabolomics Technology

Exhibit 50: Metabolomics (2005-2012) - United Kingdom Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)

Exhibit 51: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of United Kingdom Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million

B3. Italy

Italian Market Analysis

Analysis by Metabolomics Technology

Exhibit 52: Metabolomics (2005-2012) - Italian Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)

Exhibit 53: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Italian Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million

B4. Belgium

Belgian Market Analysis

Analysis by Metabolomics Technology

Exhibit 54: Metabolomics (2005-2012) - Belgian Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)

Exhibit 55: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Belgian Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million

B5. France

French Market Analysis

Analysis by Metabolomics Technology

Exhibit 56: Metabolomics (2005-2012) - French Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)

Exhibit 57: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of French Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million

B6. Spain

Spanish Market Analysis

Analysis by Metabolomics Technology

Exhibit 58: Metabolomics (2005-2012) - Spanish Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)

Exhibit 59: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Spanish Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million

B7. Switzerland

Swiss Market Analysis

Analysis by Metabolomics Technology

Exhibit 60: Metabolomics (2005-2012) - Swiss Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)

Exhibit 61: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Swiss Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million

B8. Sweden

Swedish Market Analysis

Analysis by Metabolomics Technology

Exhibit 62: Metabolomics (2005-2012) - Swedish Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)

Exhibit 63: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Swedish Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million

B9. Rest of Europe

Rest of Europe Market Analysis

Analysis by Metabolomics Technology

Exhibit 64 Metabolomics (2005-2012) - Rest of Europe Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)

Exhibit 65: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Rest of Europe Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million

C. Japan

Market Analysis

Exhibit 66: Metabolomics (2005-2012) - Japanese Market Analysis (Current & Future) in US$ Million (Graphical Representation included)

Exhibit 67: List of Major Companies in Japan

Analysis by Metabolomics Technology

Exhibit 68: Metabolomics (2005-2012) - Japanese Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)

Exhibit 69: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Japanese Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million

D. Asia-Pacific

Market Analysis

Exhibit 70: Metabolomics (2005-2012) - Asia-Pacific Market Analysis (Current & Future) in US$ Million (Graphical Representation included)

Exhibit 71: List of Major Companies in Asia-Pacific

Analysis by Geographic Region

Exhibit 72: Metabolomics (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Geographic Region for China, India, Australia and Rest of Asia-Pacific in US$ Million (Graphical Representation included)

Exhibit 73: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Geographic Region for China, India, Australia and Rest of Asia-Pacific (Graphical Representation included)

Analysis by Metabolomics Technology

Exhibit 74: Metabolomics (2005-2012) - Asia-Pacific Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)

Exhibit 75: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Asia-Pacific Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)

Asia-Pacific Market Analysis by Country

D1. China

Chinese Market Analysis

Analysis by Metabolomics Technology

Exhibit 76: Metabolomics (2005-2012) - Chinese Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)

Exhibit 77: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Chinese Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million

D2. India

Indian Market Analysis

Analysis by Metabolomics Technology

Exhibit 78: Metabolomics (2005-2012) - Indian Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)

Exhibit 79: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Indian Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million

D3. Australia

Australian Market Analysis

Analysis by Metabolomics Technology

Exhibit 80: Metabolomics (2005-2012) - Australian Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)

Exhibit 81: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Australian Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million

D4. Rest of Asia-Pacific

Rest of Asia-Pacific Market Analysis

Analysis by Metabolomics Technology

Exhibit 82: Metabolomics (2005-2012) - Rest of Asia-Pacific Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)

Exhibit 83: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Rest of Asia-Pacific Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million

E. Canada

Market Analysis

Exhibit 84: Metabolomics (2005-2012) - Canadian Market Analysis (Current & Future) in US$ Million (Graphical Representation included)

Exhibit 85: List of Major Companies in Canada

Analysis by Metabolomics Technology

Exhibit 86: Metabolomics (2005-2012) - Canadian Market Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)

Exhibit 87: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Canadian Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)

F. Rest of World

Market Analysis

Exhibit 88: Metabolomics (2005-2012) - Rest of World Market Analysis (Current & Future) in US$ Million (Graphical Representation included)

Exhibit 89: List of Major Companies in Rest of World

Analysis by Metabolomics Technology

Exhibit 90: Metabolomics (2005-2012) - Rest of World Analysis (Current & Future) by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)

Exhibit 91: Metabolomics (2006, 2009 and 2012) - Percentage Breakdown of Rest of World Market Value by Metabolomic Technologies for Combined Systems, Hardware Systems and Software Systems in US$ Million (Graphical Representation included)

6. Metabolomics - The Industry Outlook

V. CORPORATE DIRECTORY

Abstract

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.